Table 1.
Method | Description, advantages (+) and disadvantages (−) |
---|---|
Cannulation studies Used to study: Lymph node (LN) exit (efferent lymph) Entry into afferent lymphatic vessels (LVs) (afferent lymph) |
Lymph fluid is collected via a cannula placed directly inside an afferent or efferent LV, or into the cisterna chyli. Its cellular content is subsequently characterized by microscopy or flow cytometry. Cannulation studies are typically performed in larger animals/humans, and more rarely also in rodents (Gowans 1957; Mackay et al. 1988; Yawalkar et al. 2000; Zawieja et al. 2019).
|
Adoptive transfer (I) (e.g., injected subcutaneously or into the footpad) Used to study: Entry into afferent LVs Entry from afferent LVs into LNs |
Fluorescently labeled or otherwise marked leukocytes (e.g., expressing a fluorescent protein or congenic marker) are injected into peripheral tissues of recipient mice and their presence in the draining LN (dLN) is subsequently quantified by flow cytometry or immunofluorescence. Common sites of injection are the ear skin or footpad, as they mainly drain into one single LN (i.e., the auricular or popliteal LN, respectively). In some cases, intralymphatic injection is also used (Ohl et al. 2004; Johnson et al. 2006; Brinkman et al. 2016; Teijeira et al. 2017; Martens et al. 2020).
To study the residence time of T cells in LNs, a special adoptive transfer setup is used. Specifically, fluorescently labeled T cells are first transferred intravenously into a recipient mouse from where they home to LNs. After a few hours, further immigration of T cells into LNs via high endothelial venules (HEVs) is blocked by administration of entry-blocking antibodies (e.g., anti-integrin α4 or anti-L-selectin). In this way, T-cell entry is uncoupled from egress, which will continue to occur. To quantify LN egress, the number of fluorescent T cells in the LNs at the time of antibody injection is determined by quantitative flow cytometry and compared to the number found in the LNs in the control and the treatment group (or wild-type [WT] vs. knockout [KO]) at a certain end point (e.g., 24 h). If egress is inhibited, more T cells should be present in the LN in the treated (or KO) group at the end point (Halin et al. 2005; Pham et al. 2010; Reichardt et al. 2013).
|
Adoptive transfer (II) Intravenous injection Used to study LN egress | |
FITC/TRITC painting Used to study: Entry into afferent LVs Entry from afferent LVs into LNs |
Topical or intranasal/intratracheal administration of fluorescein isothiocyanate (FITC) or TRITC allows analysis of the endogenous migration of DCs from the skin or lung, respectively. FITC or TRITC is taken up by dermal or pulmonary DCs, which subsequently can be identified in dLNs by flow cytometry or microscopy (Förster et al. 1999; Qu et al. 2004; Vigl et al. 2011; Iolyeva et al. 2013).
|
Photoconvertible transgenic mice Used to study: Migration via afferent LVs to LNs |
Performed in mice ubiquitously expressing a photoconvertible green- fluorescent protein (e.g., Kikume or Kaede protein), which is converted to a red-fluorescent state upon illumination with (ultra)violet light. Migratory photoconverted cells can be tracked by their red fluorescence and detected and quantified by flow cytometry in tissues like LNs (Tomura et al. 2008, 2010; Bromley et al. 2013; Tadayon et al. 2021).
|
Intravital microscopy Used to study: Entry/migration within afferent LVs Entry into or exit from LNs across lymphatic sinuses |
Fluorescent reporter mice adoptively transferred fluorescently labeled leukocytes or injected fluorescent antibodies are used to visualize LVs and leukocytes in vivo. The migration of leukocytes is studied at the single-cell level by time-lapse confocal or multiphoton microscopy to determine (e.g., the speed, directionality, or cellular interactions of migrating cells). Common imaging sites are the popliteal LNs, ear skin, or footpads (Grigorova et al. 2010; Tal et al. 2011; Teijeira et al. 2017; Hunter et al. 2019).
|
Skin explants Used to study: Migration toward, into, and within afferent LVs |
Murine ear skin is ripped along the central cartilage and fluorescently labeled leukocytes are added on top of the luminal side of the explant and left to migrate into the dermal tissue. Migration into afferent lymphatics is analyzed after ∼1–4 h by confocal microscopy after staining LVs with fluorescent antibodies. Alternatively, migration of fluorescent leukocytes can be assessed in real time by performing time-lapse imaging in explants with fluorescent LVs (either stained by antibodies or endogenously visualized in LV reporter mice) (Lämmermann et al. 2008; Teijeira et al. 2013; Russo et al. 2016; Johnson et al. 2017).
|
In vitro assays Used to study: Adhesion Transmigration Crawling |
Specific migration steps, such as transmigration, adhesion, or crawling, can be investigated by in vitro functional assays using lymphatic endothelial cell (LEC) monolayers and ex vivo isolated or in vitro differentiated/activated leukocytes (Ledgerwood et al. 2008; Russo et al. 2016; Arasa et al. 2021; Johnson et al. 2021).
|